Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host

Meyer-Luehmann, Melanie, Coomaraswamy, Janaky, Bolmont, Tristan, Kaeser, Stephan, Schaefer, Claudia, Kilger, Ellen, Neuenschwander, Anton, Abramowski, Dorothee, Frey, Peter, Jaton, Anneliese L., Vigouret, Jean-Marie, Paganetti, Paolo, Walsh, Dominic M., Mathews, Paul M., Ghiso, Jorge, Staufenbiel, Matthias, Walker, Lary C., Jucker, Mathias·2006·Science
DOI 10.1126/science.1131864

Cited by (970)

Items 701–800 of 970

  1. Brain aging and Alzheimer’s disease, a perspective from non-human primates
    Isidró Ferrer · 2024 · Aging
  2. The role of microglia in the prion-like transmission of protein aggregates in neurodegeneration
    Muhammet M Öztürk, Jakob Emgård, Juan García‐Revilla, Rosalía Fernández‐Calle, Yiyi Yang, Tomas Deierborg, Tomas T. Roos · 2025 · Brain Communications
  3. Protein Misfolding Cyclic Amplification
    Fabio Moda, Sandra Pritzkow, Claudio A. Soto · 2012 · Springer eBooks
  4. Peripheral administration of SOD1 aggregates does not transmit pathogenic aggregation to the CNS of SOD1 transgenic mice
    Isil Keskin, Elaheh Ekhtiari Bidhendi, Matthew Marklund, Peter Munch Andersen, Thomas Brännström, Stefan L. Marklund, Ulrika Nordström · 2021 · Acta Neuropathologica Communications
  5. Distinct Effects of Beta-Amyloid, Its Isomerized and Phosphorylated Forms on the Redox Status and Mitochondrial Functioning of the Blood–Brain Barrier Endothelium
    Aleksandra V. Petrovskaya, Artem M. Tverskoi, Evgeny P. Barykin, Kseniya B. Varshavskaya, Alexandra A. Dalina, Vladimir A. Mitkevich, Alexander А. Makarov, Irina Yu. Petrushanko · 2022 · International Journal of Molecular Sciences
  6. A New Story about an Old Guy: Is Alzheimer’s Disease Infectious?
    Helton José Reis, Marat A. Mukhamedyarov, Albert Anatolyevich Rizvanov, András Palotás · 2010 · Neurodegenerative Diseases
  7. Peculiarities of Prion Diseases
    Walker S. Jackson, Clemens Krost · 2014 · PLoS Pathogens
  8. Is Covalently Crosslinked Aβ Responsible for Synaptotoxicity in Alzheimers Disease?
    Ryan Naylor, Andrew Francis Hill, Kevin Jeffrey Barnham · 2008 · Current Alzheimer Research
  9. Protein Misfolding Cyclic Amplification of Infectious Prions
    Fabio Moda · 2017 · Progress in molecular biology and translational science
  10. Strains of Pathological Protein Aggregates in Neurodegenerative Diseases
    Xinzhu Wang, Zeinab Noroozian, Madelaine Lynch, Nicholas Armstrong, Raphaël Schneider, Mingzhe Liu, Farinaz Ghodrati, Ashley B. Zhang, Yoo Jeong Yang, Amanda C. Hall et al. · 2017 · Discoveries
  11. Ubiquitination and SUMOylation of Amyloid and Amyloid-like Proteins in Health and Disease
    Lenzie K. Ford, Luana Fioriti, Eric R. Kandel · 2019 · Current Issues in Molecular Biology
  12. Telomere length and oxidative stress variations in a murine model of Alzheimer’s disease progression
    Martínez‐González, Katia, Islas‐Hernández, Azul, Martínez‐Ezquerro, José Darío, Bermúdez‐Rattoni, Federico, Garcia‐delaTorre, Paola · 2020 · European Journal of Neuroscience
  13. Aberrant interactions between amyloid-beta and alpha5 laminins as possible driver of neuronal disfunction in Alzheimer’s disease
    Sergey Rodin, Sergey A. Kozin, Olga I. Kechko, Vladimir A. Mitkevich, Alexander А. Makarov · 2020 · Biochimie
  14. PET imaging of alpha-synuclein: from radiotracer design through in vitro and in vivo translation
    Anna Pees, Ann-Kathrin Grotegerd, Daniel Bleher, Kristina Herfert, Neil Vasdev · 2026 · European Journal of Nuclear Medicine and Molecular Imaging
  15. Deciphering the prion-like behavior of pathogenic protein aggregates in neurodegenerative diseases
    Shun Yoshida, Takafumi Hasegawa · 2022 · Neurochemistry International
  16. Alimentary prion infections
    Bianca Da Costa Dias, Katarina Jovanovic, Stefan F. T. Weiss · 2011 · Prion
  17. Alzheimer’s Disease and Dementia
    Patrick Alfryn Lewis, Jennifer E. Spillane · 2018 · Elsevier eBooks
  18. Blood Transfusion and Brain Amyloidosis
    Steven Mark Greenberg · 2023 · JAMA
  19. Transmissible long-term neuroprotective and pro-cognitive effects of 1–42 beta-amyloid with A2T icelandic mutation in an Alzheimer’s disease mouse model
    Marina Célestine, Muriel R. Jacquier‐Sarlin, Eve Borel, Fanny Petit, Fabien Lanté, Luc Bousset, Anne‐Sophie Hérard, Alain Buisson, Marc Dhénain · 2024 · Molecular Psychiatry
  20. Inactivation of seeding activity of amyloid β‐protein aggregates in vitro
    Hiroto Nakano, Tsuyoshi Hamaguchi, Tokuhei Ikeda, Takahiro Watanabe‐Nakayama, Kenjiro Ono, Masahito Yamada · 2021 · Journal of Neurochemistry
  21. Seed-induced Aβ deposits in the corpus callosum disrupt white matter integrity in a mouse model of Alzheimer’s disease
    Vanessa Aires, Stephanie Ziegler‐Waldkirch, Marina Friesen, Wilfried Reichardt, Daniel Erny, Desirée Loreth, Andrew Christopher Harborne, Oliver Kretz, Dominik von Elverfeldt, Melanie Meyer‐Luehmann · 2022 · Frontiers in Cellular Neuroscience
  22. The importance of prion research
    Shehab Eid, Seojin Lee, Claire E. Verkuyl, Dustin Loren Almanza, Joseph Hanna, Sandra Shenouda, Ari Belotserkovsky, Wenda Zhao, Joel C. Watts · 2024 · Biochemistry and Cell Biology
  23. Estimation of phosphorylation level of amyloid-beta isolated from human blood plasma: Ultrahigh-resolution mass spectrometry
    Igor A. Popov, Maria I. Indeykina, Пеков Станислав Игоревич, Natalia L. Starodubtseva, Alexey S. Kononikhin, M. I. Nikolaeva, Evgenii Kukaev, Yury Kostyukevich, Sergey A. Kozin, Alexander А. Makarov et al. · 2014 · Molecular Biology
  24. Neuropathologie morphologique et moléculaire de la maladie d’Alzheimer
    Charles J. Duyckaerts, Maı̈ Panchal, Benoı̂t Delatour, Marie‐Claude Potier · 2009 · Annales Pharmaceutiques Françaises
  25. Seeding plaques in Alzheimer’s disease
    Marco A. M. Prado, Gerald S. Baron · 2011 · Journal of Neurochemistry
  26. Small RNA drugs for prion disease: a new frontier
    Amrit S. Boese, Anna Majer, Reuben Saba, Stephanie A. Booth · 2013 · Expert Opinion on Drug Discovery
  27. Prions and Non-infectious Amyloids of Mammals – Similarities and Differences
    Alexey P. Galkin, Maria E. Velizhanina, Julia V. Sopova, Aleksandr A. Shenfeld, Sergey P. Zadorsky · 2018 · Biochemistry (Moscow)
  28. Role of Prion Protein Oligomers in the Pathogenesis of Transmissible Spongiform Encephalopathies
    Rodrigo Morales, Claudia A. Duran-Aniotz, Claudio A. Soto · 2011 · Springer eBooks
  29. On the issue of transmissibility of Alzheimer disease
    Christian Schmidt, André Karch, Carsten Korth, Inga Zerr · 2012 · Prion
  30. Renewed assessment of the risk of emergent advanced cell therapies to transmit neuroproteinopathies
    Paul A. De Sousa, Diane L. Ritchie, A.J.E Green, Siddharthan Chandran, Richard Knight, Mark W. Head · 2018 · Acta Neuropathologica
  31. Breakthroughs in antemortem diagnosis of neurodegenerative diseases
    Glenn C. Telling · 2019 · Proceedings of the National Academy of Sciences
  32. Infectious prions and proteinopathies
    Rona M. Barron · 2017 · Prion
  33. Toxic mechanisms of amyloid oligomers and therapeutic strategies
    Magdalena I. Ivanova, Carmelo La Rosa, Ayyalusamy Ramamoorthy · 2026 · Protein Science
  34. Beta-Amyloid Related Neurodegenerative and Neurovascular Diseases: Potential Implications for Transfusion Medicine
    Ryan T. Muir, Jeannie L. Callum, Amy Yu, Moira K. Kapral, Richard H. Swartz, Sandra E. Black, Bradley J. MacIntosh, Dean A. Fergusson, Steven H Kleinman, Andrew M. Demchuk et al. · 2024 · Transfusion Medicine Reviews
  35. Infections, genetics, and Alzheimer's disease: Exploring the pathogenic factors for innovative therapies
    Ramesh Kordi, Ted J. Andrews, Mark Daniel Hicar · 2025 · Virology
  36. New biomarkers and drug targets for diagnosis and therapy of Alzheimer’s disease (molecular determinants of zinc-dependent oligomerization of β-amyloid)
    Sergey A. Kozin, Alexander А. Makarov · 2015 · S S Korsakov Journal of Neurology and Psychiatry
  37. Alkannin Attenuates Amyloid β Aggregation and Alzheimer’s Disease Pathology
    Toru Hosoi, Kyosuke Yazawa, Michihiro Imada, Akari Tawara, Chihiro Tohda, Yasuyuki Nomura, Koichiro Ozawa · 2023 · Molecular Pharmacology
  38. Long term worsening of amyloid pathology, cerebral function, and cognition after a single inoculation of beta-amyloid seeds with Osaka mutation
    Marina Célestine, Muriel R. Jacquier‐Sarlin, Eve Borel, Fanny Petit, J. Pérot, Anne‐Sophie Hérard, Luc Bousset, Alain Buisson, Marc Dhénain · 2023 · Acta Neuropathologica Communications
  39. NOSH aspirin may have a protective role in Alzheimer’s disease
    Gabi Drochioiu, Lucia Tudorachi, Manuela Murariu · 2015 · Medical Hypotheses
  40. β-Amyloid Fibril Structures, In Vitro and In Vivo
    Robert Tycko · 2013 · Research and perspectives in Alzheimer's disease
  41. Non-human primates in prion diseases
    Emmanuel E. Comoy, Jacqueline Mikol, Jean‐Philippe Deslys · 2022 · Cell and Tissue Research
  42. Prion Protein Aggregation and FibrillogenesisIn Vitro
    Jan Stöhr · 2012 · Sub-cellular biochemistry/Subcellular biochemistry
  43. Decontamination of prions
    G. McDonnell, Emmanuel E. Comoy · 2019 · Elsevier eBooks
  44. Prion Diseases
    Robert C.C. Mercer, Alex James McDonald, Erin Bove‐Fenderson, Cheng Fang, Bei Wu, David A. Harris · 2018 · Elsevier eBooks
  45. A closer look at pathogenic amyloid-β in Alzheimer’s disease using cryo-electron microscopy: a narrative review
    Yang Gao, Sophia Schedin‐Weiss, Lars O. Tjernberg · 2024 · Advanced technology in neuroscience .
  46. The mechanisms of prion disease.
    Andrew C. Gill, Fiona M. Lane, James D. Alibhai, Jean C. Manson, Sandra McCutcheon · 2012 · CABI Reviews
  47. Hat die Alzheimer-Forschung versagt?
    Christian Haass, Johannes Levin · 2019 · Der Nervenarzt
  48. Novel immunological approaches for the treatment of Alzheimer's disease.
    Priyanka Sabharwal, Thomas Wısnıewskı · 2014 · PubMed
  49. Alzheimer’s Disease: Insights from Genetic Mouse Models and Current Advances in Human IPSC-Derived Neurons
    Anne E. Harasta, Lars Matthias Ittner · 2017 · Advances in neurobiology
  50. Is Alzheimer’s Disease Transmissible in Humans?
    Xian‐Le Bu, Weiwei Li, Yan‐Jiang Wang · 2019 · Neuroscience Bulletin
  51. Prion Diseases
    Pawel Piotr Liberski, James W. Ironside · 2014 · Elsevier eBooks
  52. Distinct Aβ pathology in the olfactory bulb and olfactory deficits in a mouse model of Aβ and α‐syn co‐pathology
    Marina Friesen, Stephanie Ziegler‐Waldkirch, Milena Egenolf, Paolo d’Errico, Christina Helm, Charlotte Mezö, Nikolaos Dokalis, Daniel Erny, Natalie Katzmarski, Romina Coelho et al. · 2021 · Brain Pathology
  53. Structural Biology of PrP Prions
    Gerald Stubbs, Jan Stöhr · 2016 · Cold Spring Harbor Perspectives in Medicine
  54. The Determinant of Tau Spreading in Alzheimer’s Disease: Dependent on Senile Plaque, Neural Circuits, or Spatial Proximity?
    Yuichi Riku, Jean‐Pierre Brion, Kunié Ando, Toshiki Uchihara, Yasushi Iwasaki · 2025 · International Journal of Molecular Sciences
  55. Expanding the prion disease repertoire
    Surachai Supattapone · 2015 · Proceedings of the National Academy of Sciences
  56. Could it be that neurodegenerative diseases are infectious?
    Pascal Derkinderen · 2019 · Revue Neurologique
  57. Methods for Studying and Structure–Function Relationships of Non-Fibrillar Protein Assemblies in Alzheimer's Disease and Related Disorders
    Farid Rahimi and Gal Bitan · 2014 · BENTHAM SCIENCE PUBLISHERS eBooks
  58. Angiopatía amiloide cerebral unilateral tras una neurointervención
    A. Lázaro Romero, C. Moreno Loscertales, Eugenia Marta Moreno · 2021 · Neurología
  59. High-avidity binding drives nucleation of amyloidogenic transthyretin monomer
    Li Gao, Xinfang Xie, Pan Liu, Jing Jin · 2022 · JCI Insight
  60. Unilateral cerebral amyloid angiopathy after neurointervention
    A. Lázaro Romero, C. Moreno Loscertales, Eugenia Marta Moreno · 2022 · Neurología (English Edition)
  61. The effect of Aβ seeding is dependent on the presence of knock-in genes in the AppNL−G−F mice
    Sean G. Lacoursiere, Jiri Safar, David A. Westaway, Majid H. Mohajerani, Robert J. Sutherland · 2022 · Frontiers in Dementia
  62. New developments in prion disease research
    Sabine Gilch, Hermann M. Schätzl · 2023 · Cell and Tissue Research
  63. Neuroinflammation in Alzheimer's disease
    Mohit Agrawal, Manmohan Singhal, Bhupendra Gopalbhai Prajapati, Hema Chaudhary, Yash Jasoria, Bhavna Kumar, Mandeep Kumar Arora, Jagannath Sahoo · 2024 · Elsevier eBooks
  64. A New Interpretative Paradigm for Conformational Protein Diseases
    Luigi F. Agnati, Diego Guidolin, Amina S. Woods, Francisco Ciruela, Chiara Carone, Annamaria Vallelunga, Dasiel Oscar Borroto Escuela, Susanna Genedani, Kjell Fuxé · 2013 · Current Protein and Peptide Science
  65. Roles of microRNAs in Parkinson’s and other neurodegenerative diseases
    Qingxuan Lai, Nicola Murgia, Ilmari Parkkinen, Andrii Domanskyi, Ilya A. Vinnikov · 2019 · Elsevier eBooks
  66. Amyloid-β in the Cerebrospinal Fluid of APP Transgenic Mice Does not Show Prion-like Properties
    Zhiva Kalinova Skachokova, Frederik Sprenger, Karin Breu, Dorothée Abramowski, Florence Clavaguera, Jürgen Hench, Matthias Staufenbiel, Markus Tolnay, David T. Winkler · 2015 · Current Alzheimer Research
  67. Transmissible Spongiform Encephalopathies
    Markus Glatzel, Adriano Aguzzi · 2015 · ASM Press eBooks
  68. Monitoring Cell-to-cell Transmission of Prion-like Protein Aggregates in Drosophila Melanogaster
    Kirby M. Donnelly, Margaret M.P. Pearce · 2018 · Journal of Visualized Experiments
  69. One or more β-amyloid(s)? New insights into the prion-like nature of Alzheimer's disease
    Marcella Catania, Giuseppe Di Fede · 2020 · Progress in molecular biology and translational science
  70. Editorial: Pathogenic templating proteins in Neurodegenerative Disease
    Laura A. Volpicelli‐Daley, Patrik Brundin · 2017 · Neurobiology of Disease
  71. Reduced protein solubility – cause or consequence in amyloid disease?
    Max Lindberg, Jing Hu, Emma Sparr, Sara Snogerup Linse · 2025 · QRB Discovery
  72. In Vivo Seeding of Amyloid-β Protein and Implications in Modeling Alzheimer’s Disease Pathology
    Qianmin Liu, Simin Song, Lu Liu, Wei Hong · 2025 · Biomolecules
  73. Human and Mouse Alzheimer's Seeds Differentially Affect Amyloid Deposition and Microglia‐Dependent Plaque Response in Aged Mice
    Juana Andreo‐Lopez, Cristina Nuñez‐Diaz, Kelly Do Huynh, Marie Minh Thu Nguyen, Celia Da Cunha, Francisco Cantero‐Molina, Cynthia Campos‐Moreno, Stefania Zimbone, Francesco Bellia, Maria Laura Giuffrida et al. · 2025 · Aging Cell
  74. Cognitive Impairment and Early-onset Cerebral Amyloid Angiopathy in a Middle-aged Man with a History of Childhood Traumatic Brain Injury
    Kosuke Suzuki, Takuya Ataka, Noriyuki Kimura, Etsuro Matsubara · 2024 · Internal Medicine
  75. Differential accumulation of human β-amyloid and tau from enriched extracts in neuronal and endothelial cells
    Yoana Rabanal‐Ruiz, Cristina M. Pedrero-Prieto, Luis Sánchez Rodríguez, Alicia Flores‐Cuadrado, Daniel Saiz‐Sánchez, Javier Frontiñán-Rubio, Isabel Úbeda‐Bañón, Mario Durán‐Prado, Alino Martínez-Marcos, Juan R. Peinado · 2024 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  76. Synthetic Aβ peptides acquire prion-like properties in the brain
    Xiangzhu Xiao, Ignazio Calì, Jue Yuan, Laura Cracco, Paul Curtiss, Liang Zeng, Mai Abouelsaad, Dimitris Gazgalis, Gong-Xian Wang, Qingzhong Kong et al. · 2014 · Oncotarget
  77. Neurodegenerative Disorders and Prionopathies
    Nae J. Dun · 2013 · Journal of Neurology & Neurophysiology
  78. Impact of Sterilization Methods on the Seeding Ability of Human Tau Proteopathic Seeds
    Analiese R. Fernandes, Simon Dujardin, Anastasie Maté de Gérando, Bradley T. Hyman, Matthew P. Frosch · 2021 · Journal of Neuropathology & Experimental Neurology
  79. Development of amyloid beta gold nanorod aggregates as optoacoustic probes
    Mahmoud G. Soliman, Hannah A. Davies, Jack W. Sharkey, Raphaël Lévy, Jillian Madine · 2022 · PLoS ONE
  80. Distinct Heterocyclic Moieties Govern the Selectivity of Thiophene‐Vinylene‐Based Ligands towards Aβ or Tau Pathology in Alzheimer's Disease
    Linnea Björk, Hamid Shirani, Yogesh Todarwal, Mathieu Linares, Rubén Vidal, Bernardino Francesco Ghetti, Patrick Norman, Therése Klingstedt, K. Peter R. Nilsson · 2023 · European Journal of Organic Chemistry
  81. Efficient Seeding of Cerebral Vascular Aβ-Amyloidosis by Recombinant AβM1-42 Amyloid Fibrils
    Farjana Parvin, Johan N. K. Larsson, Walker S. Jackson, Sofie Nyström, Per Hammarström · 2024 · Journal of Molecular Biology
  82. The Aβ Containing Brain Extracts Having Different Effects in Alzheimer’s Disease Transgenic Caenorhabditis elegans and Mice
    Yufang Yang, Mo Wang, Ping Yang, Zishan Wang, Li Huang, Jing Xu, Wei Wang, Mei Yu, Liping Bu, Jian Fei et al. · 2018 · Frontiers in Aging Neuroscience
  83. Discovery of Chemicals to Either Clear or Indicate Amyloid Aggregates by Targeting Memory‐Impairing Anti‐Parallel Aβ Dimers
    Jinny Claire Lee, Hye Yun Kim, Sejin Lee, Jisu Shin, Hyunjin Vincent Kim, Kyeonghwan Kim, Seungyeop Baek, Dong-Hee Lee, Hanna Jeon, DaWon Kim et al. · 2020 · Angewandte Chemie
  84. Transmissible Spongiform Encephalopathies and Decontamination
    Gerald E. McDonnell · 2012 · Wiley-Blackwell eBooks
  85. Synthesis of the β-amyloid fragment 5RHDSGY10 and its isomers
    E. Yu. Aleshina, Nadezhda V. Pyndyk, A. A. Moisa, M.A. Sanzhakov, Oleg N. Kharybin, Е. Н. Николаев, Ekaterina F. Kolesanova · 2008 · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry
  86. Symptomatic and preclinical Alzheimer’s disease: Neuropathology and imaging
    Dietmar Rudolf Thal · 2016 · Neurology Psychiatry and Brain Research
  87. Molecular architecture of Aβ fibrils grown in cerebrospinal fluid solution and in a cell culture model of Aβ plaque formation
    Megan Garvey, Monika Baumann, Melanie Wulff, Senthil T. Kumar, Daniel Markx, Isabel M Morgado, Uwe Knüpfer, Uwe Horn, Christian Mawrin, Marcus Fändrich et al. · 2016 · Amyloid
  88. α7-Nicotinic Acetylcholine Receptors and β-Amyloid Peptides in Alzheimer’s Disease
    Dietrich Ernst Lorke, Georg A. Petroianu, Murat Öz · 2016 · Neuromethods
  89. The multitude of therapeutic targets in neurodegenerative proteinopathies
    Ronald Melki · 2017 · Elsevier eBooks
  90. The Formation of Amyloid-Like Superstructures
    Vito Foderà, Athene M. Donald · 2013 · Elsevier eBooks
  91. Prion-Like Propagation in Neurodegenerative Diseases
    Wouter Peelaerts, Veerle Baekelandt, Patrik Brundin · 2018 · Elsevier eBooks
  92. Amyloid-β ‘seeds’ in old vials of growth hormone
    Tien‐Phat V. Huynh, David M. Holtzman · 2018 · Nature
  93. Altering Brain Amyloidosis by Intra-Lingual and Extra-Nasal Exposure of Aβ Aggregates
    Nazaret Gamez, Javiera B Bravo-Alegria, Yumeng Huang, Nelson Perez-Urrutia, Deepa Dongarwar, Claudio A. Soto, Rodrigo Morales · 2022 · Cells
  94. Commentary: Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy
    Isis Nem de Oliveira Souza, Evandro A. De‐Souza · 2016 · Frontiers in Aging Neuroscience
  95. Soluble Brain Homogenates from Diverse Human and Mouse Sources Preferentially Seed Diffuse Aβ Plaque Pathology When Injected into Newborn Mouse Hosts
    Brenda D. Moore, Yona Levites, Guilian M. Xu, Hailey Hampton, Munir F Adamo, Cara L. Croft, Hunter S. Futch, Corey Moran, Susan Fromholt, Christopher Janus et al. · 2021 · Research Square
  96. Cutaneous Amyloidoses
    Stephan Schreml · 2016 · Wiley eBooks
  97. Amyloid‐β Seeds in Alzheimer's Disease: Research Challenges and Implications
    Natalie Beschörner, Ying Xu, Mathias Jucker, Alejandro Ruiz‐Riquelme · 2025 · Journal of Neurochemistry
  98. Creutzfeldt–Jakob disease is an Alzheimer’s disease-related dementia
    Joel C. Watts, Christina J. Sigurdson, Debbie Yobs, Claudio A. Soto · 2026 · Trends in Molecular Medicine
  99. The aggregation of amyloid-β: from condensation, nucleation, and conformation to targeting therapy
    Bangyao Chen, Tiancheng Chen, Zhendong Sun, Lulu Liu, Yu Jia, Yipin Ji, Jinlong Wang, Feifei Sun, Yunpeng Huang · 2026 · Life Sciences
  100. Propagation of Neuronal Damage to Embryonic Grafts Transplanted in the Hippocampus of Murine Models of Alzheimer's Disease
    Mohcene Sadallah, Vivien Labat-gest, Filippo Tempia · 2015 · Rejuvenation Research